Streetbeat News

Stock Prices

EMR

Loop Capital analyst Chris Dankert has maintained a Buy rating on Emerson Electric (EMR) and increased the price target from $130 to $135.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:25 pm

BILI

CLSA analyst Elinor Leung upgrades Bilibili (NASDAQ:BILI) from Outperform to Buy and raises the price target from $12.2 to $16.8.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:55 pm

APP

Citigroup analyst Jason Bazinet has maintained a Buy rating on AppLovin (NASDAQ:APP) and increased the price target from $80 to $98.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:36 pm

SPSC

Citigroup analyst George Kurosawa has maintained a Buy rating on SPS Commerce (NASDAQ:SPSC) and increased the price target from $213 to $222.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:29 pm

TSEM

Benchmark analyst Cody Acree has reiterated a Buy rating on Tower Semiconductor (NASDAQ:TSEM) and increased the price target from $40 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:09 pm

WTI

W&T Offshore (NYSE:WTI) reported Q1 losses of $(0.05) per share, beating the $(0.06) estimate, and sales of $140.79M, surpassing the $139.56M estimate. This represents a 150% increase in losses and a 6.88% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:04 pm

EVAX

Evaxion Biotech A/S received a notification from Nasdaq for not meeting the minimum stockholders' equity requirement.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:03 pm

TSEM

Benchmark analyst Cody Acree has reiterated a Buy rating on Tower Semiconductor (NASDAQ:TSEM) and increased the price target from $40 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:02 pm

ZEPP

Zepp Health Corporation received a NYSE non-compliance letter due to the low trading price of its ADSs, indicating it's below the required compliance standards.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:02 pm

RDNT

Analysts have diverse views on RadNet (NASDAQ:RDNT), with recent evaluations showing a mix of bullish to bearish sentiments. The average 12-month price target for RDNT has been raised to $54.4, indicating a 14.53% increase from the previous target. RadNet, a provider of diagnostic imaging services, has shown solid revenue growth but lags behind industry peers. Its net margin and ROE outperform industry averages, while its ROA and debt management raise concerns.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 9:01 pm